ESC 365 - Real-world and implementation science: insights about siRNA

Open Access

Real-world and implementation science: insights about siRNA

Session: Sustained LDL-C reduction: from long-term trials to real-world implementation

Topic: Lipid-Lowering Agents

Speaker: Doctor C. Ballantyne (Houston, US)

Sponsored by Novartis Pharma AG

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)

29 presentations

3 followers

8 more presentations in this session

Welcome and introduction

Speaker: Professor K. Ray (London, GB)

Bridging guidelines to practice: why patients remain outside of LDL-C goals

Speaker: Assistant Professor S. Kohsaka (Tokyo, JP)

Value of sustained LDL-C lowering: learnings from long-term data

Speaker: Professor K. Ray (London, GB)

Shared treatment decision making: a multidisciplinary and patient partnership approach (patient testimonial video)

Tailoring the clinical approach: who will benefit from innovative lipid-lowering therapies?

Speaker: Professor D. Connolly (Birmingham, GB)

Access the full session

Sustained LDL-C reduction: from long-term trials to real-world implementation

Speakers: Doctor C. Ballantyne, Professor K. Ray, Assistant Professor S. Kohsaka, Professor K. Ray, Professor D. Connolly

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources